Latest Kaiser Health News Stories
For over a decade, federal health officials have recommended the practice, known as expedited partner therapy. It is allowed in most states, but many doctors don’t do it — either because of legal or ethical concerns, or because they are unaware of it.
Health insurers and pharmacy benefit managers are exploring how two legal provisions — which have been on the books for decades — could bring down the price tags of certain prescription medications.
California frequently innovates to address its wide-ranging health care needs, but it has not always achieved its aims. A series of articles in the journal Health Affairs shows, among other things, that efforts to care for HIV patients, provide better access to reproductive services for low-income women and fill gaps in primary care have sometimes fallen flat.
Shepherd Smith, a strong supporter of abstinence-only sex education for AIDS, has been close to the new director of the CDC for decades. This connection is just one example of the “new in crowd” surrounding the Trump administration, where politics and religion mix.
It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.
Proponents say the residencies provide help dealing with increasingly difficult cases, but some nursing groups contend that the programs are not necessary.
About a dozen states have added hepatitis C to the list of medical conditions for which people can face criminal prosecution if they engage in certain activities like sex without disclosure, needle-sharing or organ donation.
Numerous advocacy groups oppose the recent decision to hold the 2020 International AIDS conference in San Francisco and Oakland, and some argue it shouldn’t be in the U.S. at all. Those who support the decision say the predominantly liberal politics of the region make it an ideal venue for sending a message about the Trump administration’s perceived retreat from leadership on AIDS.
Washington, D.C., is trying to stop new cases of HIV in the district by making sure residents who might be at risk are taking PrEP, medicine that cuts the risk of contracting the virus by 92 percent.
A lawsuit claims that a private company hired by the state public health department to manage enrollment in an AIDS drug assistance program for low-income patients inadvertently allowed unauthorized access to their medical status.
Critics say the Trump administration failed to properly vet Dr. Robert Redfield as they attribute a pattern of “ethically and morally questionable behavior” to him.
The pill, known as PrEP, can reduce the risk of contracting the virus that causes AIDS by 90 percent. Its use has expanded sharply in recent years — but primarily among a white demographic.
In a low-tech snafu, information about HIV treatment was visible through the cellophane window on envelopes sent to about 12,000 consumers.
The hurricane closed pharmacies and clinics for a week or longer. Floodwaters spoiled drugs. People who fled to other states couldn’t get their prescriptions filled for HIV medicine.
The small federal program once based funding on an area’s cumulative number of cases. It will now be more responsive to places where new outbreaks are occurring.
Dr. Jerome Adams is the health commissioner in Indiana, the home state of Vice President Mike Pence.
Senior citizens have to be patient and keep close records to appeal when Medicare plans refuse to cover their medicines.
The federal health law made it feasible for the AIDS Drug Assistance Program to expand its efforts and help patients buy marketplace insurance plans to cover drugs and other health care.
The company tasked with enrolling eligible patients in an HIV assistance program failed to keep an online enrollment portal working effectively and violated other contract terms, the public health agency said.
African-American women are more likely to be infected with HIV than other women. So the District of Columbia is launching an effort to inform them about PrEP, medication that can reduce their risk.